GLA
EVH icon

Great Lakes Advisors’s Evolent Health EVH Stock Holding History

Great Lakes Advisors’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-75,165
Closed -$301K – 820
2025
Q4 		$301K Sell
75,165
-35,424
-32% -$197K ﹤0.01% 691
2025
Q3 		$936K Buy
+110,589
New +$1.07M 0.01% 533
2022
Q1 		– Sell
-787,934
Closed -$21.8M – 720
2021
Q4 		$21.8M Sell
787,934
-13,903
-2% -$399K 0.33% 99
2021
Q3 		$24.9M Sell
801,837
-30,381
-4% -$729K 0.39% 78
2021
Q2 		$17.6M Sell
832,218
-5,612
-0.7% -$112K 0.27% 120
2021
Q1 		$16.9M Buy
837,830
+37,387
+5% +$711K 0.27% 121
2020
Q4 		$12.8M Sell
800,443
-36,056
-4% -$477K 0.23% 131
2020
Q3 		$10.4M Buy
+836,499
New +$9.84M 0.22% 134

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Great Lakes Advisors's EVH Position: Q1 2026 in Review

Great Lakes Advisors sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 75,165 shares — an estimated $301K sold.

Great Lakes Advisors first reported a position in EVH in Q3 2020 and held it in 8 quarters. The position peaked at $24.9M in Q3 2021. 192 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Great Lakes Advisors reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
  • Great Lakes Advisors sold 75,165 Evolent Health shares in Q1 2026, an estimated $301K.
  • Great Lakes Advisors first reported a position in Evolent Health in Q3 2020 and held it in 8 quarters.
  • Great Lakes Advisors's Evolent Health position peaked at $24.9M in Q3 2021.
  • 192 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Great Lakes Advisors's 13F filing for Q1 2026, filed 12 May 2026.